Global Acid Reducer Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Acid Reducer Market Insights, Forecast to 2034
Acid-reducing medicines work in two ways. H2 blockers and proton pump inhibitors (PPIs) lower the amount of acid your stomach makes. They don't work on the acid that's already there. Antacids work by making stomach juices less acidic. But your heartburn may come back as your stomach makes more acid.
Market Analysis and InsightsGlobal Acid Reducer Market
Global Acid Reducer market is expected to reach to US$ 6355 million in 2024, with a positive growth of %, compared with US$ 6124 million in 2022. Backed with the increasing demand from downstream industries, Acid Reducer industry is evaluated to reach US$ 7721.8 million in 2029. The CAGR will be 3.3% during 2024 to 2029.
Globally, Acid Reducer key companies include AstraZeneca, Pfizer, GlaxoSmithKline, Johnson&Johnson, Xiuzheng Pharma, Sanofi, Reddy's Laboratories, Sanofi-Aventis and Hi-Tech Pharmacal, etc. AstraZeneca, Pfizer, GlaxoSmithKline are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Acid Reducer were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Acid Reducer market and estimated to attract more attentions from industry insiders and investors.
Acid Reducer can be divided into Histamine Antagonists and Proton Pump Inhibitors, etc. Histamine Antagonists is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Acid Reducer is widely used in various fields, such as OTC Drug and Rx Drug, etc. OTC Drug provides greatest supports to the Acid Reducer industry development. In 2022, global % revenue of Acid Reducer went into OTC Drug filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Acid Reducer market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Acid Reducer market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
AstraZeneca
Pfizer
GlaxoSmithKline
Johnson&Johnson
Xiuzheng Pharma
Sanofi
Reddy's Laboratories
Sanofi-Aventis
Hi-Tech Pharmacal
Apotex
Mylan
Sandoz
Strides Pharma Science
Geri-Care Pharmaceuticals
Uquifa
Teva Pharmaceuticals
Glenmark Generics
Takeda Pharmaceutical
Reckitt Benckiser
Bayer
Procter&Gamble
Reddy'sLaboratories
Segment by Type
Histamine Antagonists
Proton Pump Inhibitors
OTC Drug
Rx Drug
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Acid Reducer introduction, etc. Acid Reducer Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Acid Reducer
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Acid Reducer Market
Global Acid Reducer market is expected to reach to US$ 6355 million in 2024, with a positive growth of %, compared with US$ 6124 million in 2022. Backed with the increasing demand from downstream industries, Acid Reducer industry is evaluated to reach US$ 7721.8 million in 2029. The CAGR will be 3.3% during 2024 to 2029.
Globally, Acid Reducer key companies include AstraZeneca, Pfizer, GlaxoSmithKline, Johnson&Johnson, Xiuzheng Pharma, Sanofi, Reddy's Laboratories, Sanofi-Aventis and Hi-Tech Pharmacal, etc. AstraZeneca, Pfizer, GlaxoSmithKline are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Acid Reducer were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Acid Reducer market and estimated to attract more attentions from industry insiders and investors.
Acid Reducer can be divided into Histamine Antagonists and Proton Pump Inhibitors, etc. Histamine Antagonists is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Acid Reducer is widely used in various fields, such as OTC Drug and Rx Drug, etc. OTC Drug provides greatest supports to the Acid Reducer industry development. In 2022, global % revenue of Acid Reducer went into OTC Drug filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Acid Reducer market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Acid Reducer market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Pfizer
GlaxoSmithKline
Johnson&Johnson
Xiuzheng Pharma
Sanofi
Reddy's Laboratories
Sanofi-Aventis
Hi-Tech Pharmacal
Apotex
Mylan
Sandoz
Strides Pharma Science
Geri-Care Pharmaceuticals
Uquifa
Teva Pharmaceuticals
Glenmark Generics
Takeda Pharmaceutical
Reckitt Benckiser
Bayer
Procter&Gamble
Reddy'sLaboratories
Segment by Type
Histamine Antagonists
Proton Pump Inhibitors
Segment by Application
OTC Drug
Rx Drug
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Acid Reducer introduction, etc. Acid Reducer Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Acid Reducer
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports